OMA Guidelines Bundle

Obesity Bariatric Surgery 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544295

Contents of this Issue

Navigation

Page 3 of 21

4 Bariatric Devices and Nonsurgical Procedures Sensor-Monitored Alimentary Restriction Therapy Device   ➤ Designed to slow the eating rate by reducing the volume of the oral cavity.   ➤ Supports mindful eating.   ➤ Individually fitted and worn in the upper palate while eating.   ➤ The device contains an embedded heat sensor chip that provides downloadable adherence and time data.   ➤ Safety: • Possible complications include gastric outlet obstruction with early satiety, gastric reflux, esophagitis, vomiting, gastric wall erosion or perforation, abdominal pain, pancreatitis, and early device removal. • The most common adverse effects were nausea and vomiting (23%), abdominal pain (20%), gastric reflux (14%), diarrhea/ constipation (10%), and gastric stasis (8.3%). • Mortality is low, 0.05%   ➤ Contraindications: • Prior gastric surgeries, coagulopathy, severe liver disease, upper gastrointestinal bleeding lesions, large hiatal hernia, reflux esophagitis, gastric erosions or ulcers, pregnancy, intent to conceive, substance use disorder, or any contraindication to esophagogastroduodenoscopy (EGD).   ➤ Other considerations: • Additional measures may be necessary for a patient to maintain or augment weight loss after intragastric balloon therapy, such as pharmacological therapy, bariatric surgery, or repeat balloon therapy.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity Bariatric Surgery 2026